Therapeutics, Clinical Phamacology, Molecular Pharmacology
WILL THE NINETIES BE THE DECADE WE LOST THE BATTLE AGAINST DRUG-RESISTANT MICROBES?
A PRIMARY CARE CLINICIAN'S AND CONSULTANTS GUIDE TO MEDICATING FOR PAIN AND ANXIETY ASSOCIATED WITH OUTPATIENT PROCEDURES
RAMIPRIL ENHANCES AUTONOMIC CONTROL IN ESSENTIAL HYPERTENSION
EFFECTS OF THE CALCIUM ANTAGONIST FELODIPINE ON RESTING AND STRESS TESTING BLOOD PRESSURE IN ESSENTIAL HYPERTENSION
THE DOSE-PLASMA CONCENTRATION RELATIONSHIP OF TRANEXAMIC ACID DURING SURGERY
DOSE-RELATED HEMODYNAMIC EFFECTS OF ENALAPRILAT IN PATIENTS WITH ISCHEMIC HEART DISEASE
PHARMACOKINETICS OF A NEW ANTICONVULSANT(CGP 33101) IN EPILEPTIC MALE PATIENTS AND HEALTHY MALE SUBJECTS AFTER SINGLE ASCENDING ORAL DOSES OF 400–1200 mg
A SINGLE-DOSE BIOAVAILABILITY STUDY OF PAMIDRONATE DISODIUM AFTER ORAL ADMINISTRATION AS ENCAPSULATED ENTERIC-COATED PELLETS, ENTERIC-COATED TABLETS, AND A SOLUTION TO PATIENTS WITH POSTMENOPAUSAL OSTEOPOROSIS
PHARMACOKINETICS OF PAMIDRONATE DISODIUM IN CANCER PATIENTS AFTER A SINGLE INTRAVENOUS INFUSION OF 30-, 60− OR 90-mg DOSE OVER 4 OR 24 HOURS
ANDROGENIC ACTIVITY OF ANTIANDROGENS PREDICTED BY FIT INTO DNA
CLINICAL THERAPEUTIC CONFERENCE. Vancomycin Nephrotoxicity